| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/11/2023 | Bright Health Group Inc. | BHG | Purchase | Warrant (Right to Buy) | 828.4k | $0.01 | $8.3k | See Note 3 | 08/11/2023 |
| 07/17/2023 | Savara Inc | SVRA | Purchase | Common Stock | 333.3k | $3.00 | $1000k | See Note 2 | 07/17/2023 |
| 07/05/2023 | Black Diamond Therapeutics, Inc. | BDTX | Purchase | Common Stock | 1000k | $5.00 | $5M | See Note 2 | 07/05/2023 |
| 07/03/2023 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 933.3k | $0.00 | $0 | | 07/03/2023 |
| 06/16/2023 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Common Stock | 5.7k | $2.10 | $11.9k | | 06/16/2023 |
| 06/14/2023 | Arcellx, Inc. | | Grant | Stock Option (right to buy) | 11.5k | $37.94 | $434.8k | | 06/14/2023 |
| 06/08/2023 | CRISPR Therapeutics AG | CRSP | Grant | Stock Option (Right to Buy) | 13k | $62.59 | $813.7k | | 06/08/2023 |
| 06/07/2023 | Nkarta, Inc. | NKTX | Grant | Stock Option (right to buy) | 22.5k | $4.86 | $109.4k | | 06/07/2023 |
| 06/05/2023 | CVRx, Inc. | CVRX | Grant | Stock Option (right to buy) | 12k | $12.33 | $148.1k | | 06/05/2023 |
| 06/01/2023 | Arcellx, Inc. | | Other (acquisition) | Common Stock | 113 | $0.00 | $0 | | 06/01/2023 |
| 06/01/2023 | Arcellx, Inc. | | Other (acquisition) | Common Stock | 28 | $0.00 | $0 | See Note 3 | 06/01/2023 |
| 05/16/2023 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Stock Option (right to buy) | 16.5k | $1.82 | $30k | | 05/16/2023 |
| 03/16/2023 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Common Stock | 7.1k | $1.67 | $11.9k | | 03/16/2023 |
| 01/03/2023 | Oyster Point Pharma, Inc. | OYST | Disposition | Common Stock | 10.1k | $0.00 | $0 | | 01/03/2023 |
| 01/03/2023 | Oyster Point Pharma, Inc. | OYST | Disposition | Common Stock | 3.6k | $0.00 | $0 | | 01/03/2023 |
| 01/03/2023 | Oyster Point Pharma, Inc. | OYST | Disposition | Stock Option (Right to Buy) | 5.4k | $3.63 | $19.5k | | 01/03/2023 |
| 01/03/2023 | Oyster Point Pharma, Inc. | OYST | Disposition | Stock Option (Right to Buy) | 5.2k | $17.74 | $92.2k | | 01/03/2023 |
| 12/20/2022 | Arcellx, Inc. | | Other (acquisition) | Common Stock | 57 | $0.00 | $0 | See Note 2 | 12/20/2022 |
| 12/20/2022 | Arcellx, Inc. | | Other (acquisition) | Common Stock | 226 | $0.00 | $0 | | 12/20/2022 |
| 12/16/2022 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Common Stock | 7.9k | $1.50 | $11.9k | | 12/16/2022 |
| 11/30/2022 | Akouos, Inc. | AKUS | Other | Common Stock | 4.3M | $0.00 | $0 | See Note 3 | 11/30/2022 |
| 09/16/2022 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Common Stock | 4.5k | $2.62 | $11.9k | | 09/16/2022 |
| 07/01/2022 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 737k | $0.00 | $0 | | 07/01/2022 |
| 06/17/2022 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Common Stock | 5.8k | $2.03 | $11.9k | | 06/17/2022 |
| 06/15/2022 | Monte Rosa Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 15k | $7.66 | $114.9k | | 06/15/2022 |
| 06/10/2022 | MINERVA SURGICAL INC | UTRS | Grant | Common Stock | 49.8k | $2.41 | $120k | | 06/10/2022 |
| 06/10/2022 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Stock Option (Right to Buy) | 15k | $2.14 | $32.1k | | 06/10/2022 |
| 06/09/2022 | CRISPR Therapeutics AG | CRSP | Grant | Stock Option (Right to Buy) | 12k | $71.70 | $860.4k | | 06/09/2022 |
| 06/08/2022 | Nkarta, Inc. | NKTX | Grant | Stock Option (right to buy) | 16k | $14.95 | $239.2k | | 06/08/2022 |
| 06/07/2022 | CVRx, Inc. | CVRX | Grant | Stock Option (right to buy) | 27k | $6.76 | $182.4k | | 06/07/2022 |
| 06/06/2022 | Oyster Point Pharma, Inc. | OYST | Grant | Common Stock | 3.6k | $0.00 | $0 | | 06/06/2022 |
| 06/06/2022 | Oyster Point Pharma, Inc. | OYST | Grant | Stock Option (Right to Buy) | 5.4k | $3.63 | $19.5k | | 06/06/2022 |
| 05/25/2022 | GENOCEA BIOSCIENCES, INC. | GNCA | Sale | Common Stock | 4.4M | $0.08 | $362.7k | See Note 2 | 05/24/2022 |
| 05/24/2022 | GENOCEA BIOSCIENCES, INC. | GNCA | Sale | Common Stock | 5.9M | $0.07 | $387.9k | See Note 2 | 05/24/2022 |
| 04/11/2022 | Trevi Therapeutics, Inc. | TRVI | Purchase | Common Stock | 2.6M | $1.90 | $5M | See Note 2 | 04/11/2022 |
|